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The probiotic lactic yeast *Kluyveromyces marxianus fragilis* B0399 (TURVAL B0399) is a strain belonging to a species naturally occurring in kefir and cheese, which is isolated from whey and curds of cow milk. It is the first yeast not belonging to the genus *Saccharomyces* with probiotic activity that has appeared in the market, and it was approved as a probiotic for both animal feeding ([@B1]) and human consumption ([@B2]). This strain was shown to remain viable after consumption, surpassing the gastric barrier and colonizing the gut adhering to the enterocytes of the intestinal epithelium ([@B3]). Moreover, it regulates intestinal activity during antibiotic therapy, thanks to the yeast intrinsic resistance to bacterium-targeting antibiotics ([@B4]). Furthermore, its β-galactosidase activity, absent in strains of the genus *Saccharomyces*, permits the degradation of lactose, generating glucose and galactose; therefore, it is useful in lowering the effects of lactose intolerance in susceptible individuals ([@B5]). Several *in vitro* ([@B3]) and *in vivo* ([@B4], [@B6]) experimental evidences demonstrated that *K. marxianus* B0399 is able to modulate the immune response, reducing the proinflammatory cytokine levels, thus being useful for mitigation of the effect of several diseases, such as irritable bowel syndrome ([@B6], [@B7]).

Sequencing of its genome was performed to gain more detailed information on its characteristics as a probiotic and to broaden knowledge on the genomic biodiversity in the species *K. marxianus*, since other strains whose genome sequences are available are used for bioethanol production or other applications ([@B8][@B9][@B10]).

Microbial DNA, isolated using the Wizard Genomic DNA purification kit (Promega), was used to construct three libraries with insert sizes of 578 nucleotides (nt), 626 nt, and 5 kb, which were amplified and sequenced using the Illumina HiSeq 2000 at IGA Technology Services (Udine, Italy), producing clean data containing 20 million paired reads with 150 nt at 270-fold coverage.

Trimmed reads were *de novo* assembled using AllPaths-LG version 48359 ([@B11]) with default parameters, except for TARGETS = Std., HAPLOIDIFY = T, CLOSE_UNIPATH_GAPS=F, DRY_RUN=F, MIN_CONTIG=500, and MAX_MEMORY_GB=120. The contigs were scaffolded using IMR/DENOM version 0.4.0f ([@B12]) and ordered by ScaPA release 3 (IGA Technology Services) using the genome of *K. marxianus* NBRC1777 (GenBank accession numbers AP014599 to AP014607) as a reference.

The genome sequence of B0399 was 11.44 Mb, and the G+C content was 40%. The genome was composed of eight chromosomes, including mitochondrial DNA. The assembly generated 109 scaffolds, with a maximum length of 1.3 Mb and an *N*~50~ length of 743,117 bases. A total of 5,373 putative proteins of *K. marxianus* B0399 were predicted using tBLASTn analysis against the reference genome. The key enzyme for lactose degradation (β-galactosidase) was highly similar to the corresponding enzyme from *Kluyveromyces lactis*, confirming that this yeast can be successfully used for the reduction of the effects of lactose intolerance in susceptible individuals.
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This whole-genome shotgun project has been deposited at DDBJ/ENA/GenBank under the accession no. [LXZY00000000](http://www.ncbi.nlm.nih.gov/nuccore/LXZY00000000). The version described in this paper is the first version.
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